Kevin Hershberger
CIK 1580316 · Chief Financial Officer · last filed 2017-10-06
Kevin Hershberger is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for RWLK, was dated Oct 6, 2017. Across all open-market trades the lifetime net is −$356.4K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
NXTM price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
LAWRENCE, MA 01843
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Lifeward Ltd. (RWLK) Delisted | Chief Financial Officer | 3,827 | $1.05 | $4.0K | -$1.1K | 4 | 2017-10-06 |
| NxStage Medical, Inc. (NXTM) Delisted | Chief Accounting Officer | 21,485 | — | — | -$355.3K | 8 | 2014-12-16 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-10-06 | Lifeward Ltd. (RWLK) Delisted | Mixed | +62,006 | $0 | EDGAR |
| 2017-05-22 | Lifeward Ltd. (RWLK) Delisted | Sell (S) | −980 | -$1.1K | EDGAR |
| 2017-04-20 | Lifeward Ltd. (RWLK) Delisted | Grant (A) | +19,250 | $0 | EDGAR |
| 2016-05-26 | Lifeward Ltd. (RWLK) Delisted | Grant (A) | +15,400 | $0 | EDGAR |
| 2014-12-16 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | −3,000 | -$87.8K | EDGAR |
| 2014-11-12 | NxStage Medical, Inc. (NXTM) Delisted | Mixed | −3,232 | -$105.4K | EDGAR |
| 2014-09-10 | NxStage Medical, Inc. (NXTM) Delisted | Sell (S) | −843 | -$11.4K | EDGAR |
| 2014-08-12 | NxStage Medical, Inc. (NXTM) Delisted | Sell (S) | −843 | -$11.6K | EDGAR |
| 2014-07-14 | NxStage Medical, Inc. (NXTM) Delisted | Sell (S) | −843 | -$11.4K | EDGAR |
| 2014-03-13 | NxStage Medical, Inc. (NXTM) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.